Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | FRLN | PLUR | CLDI | ||
Company | Freeline Therapeutics Holdings Plc Adss | Pluri Inc | Calidi Biotherapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
Open | 6.49 | 5.12 | 2.10 | ||
High | 6.49 | 5.29 | 2.13 | ||
Low | 6.48 | 4.73 | 1.90 | ||
Last | 6.48 | 4.98 | 1.94 | ||
Change | unch | -0.11 | -0.17 | ||
% Change | unch | -2.16% | -8.06% | ||
Volume | 5,600 | 55,600 | 1,249,500 | ||
20-Day Average Volume | 9,370 | 42,485 | 3,137,495 | ||
Previous Close | 6.48 | 5.09 | 2.11 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | No | ||
Technicals | |||||
20-Day Moving Average | 6.43 | 5.17 | 2.09 | ||
20-Day Raw Stochastic | 92.31% | 29.27% | 25.86% | ||
20-Day Relative Strength | 59.63% | 48.35% | 52.76% | ||
Weighted Alpha | +4.30 | -19.28 | -67.62 | ||
Today's Opinion | 100% Buy | 72% Sell | 8% Buy | ||
Previous Opinion | 100% Buy | 56% Sell | 24% Buy | ||
Last Month's Opinion | 88% Buy | 100% Sell | 56% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.78% since 02/09/24 | -7.78% since 11/26/24 | +0.52% since 11/26/24 | ||
Low | 6.40 on 02/12/24 | 4.73 on 12/04/24 | 1.90 on 12/04/24 | ||
High | 6.49 on 02/16/24 | 5.75 on 11/29/24 | 2.30 on 11/27/24 | ||
1-Month | |||||
%Chg | +1.09% since 01/16/24 | +9.21% since 11/04/24 | +46.97% since 11/04/24 | ||
Low | 6.36 on 01/24/24 | 4.33 on 11/05/24 | 1.26 on 11/06/24 | ||
High | 6.49 on 02/16/24 | 6.14 on 11/12/24 | 3.89 on 11/13/24 | ||
3-Month | |||||
%Chg | +37.58% since 11/16/23 | -6.04% since 09/04/24 | +68.70% since 09/04/24 | ||
Low | 4.63 on 11/17/23 | 4.27 on 10/24/24 | 0.73 on 10/25/24 | ||
High | 6.55 on 12/05/23 | 6.18 on 09/30/24 | 3.89 on 11/13/24 | ||
6-Month | |||||
%Chg | +65.73% since 08/16/23 | -13.09% since 06/04/24 | -4.90% since 06/04/24 | ||
Low | 2.60 on 10/06/23 | 4.27 on 10/24/24 | 0.73 on 10/25/24 | ||
High | 7.70 on 11/03/23 | 6.35 on 07/08/24 | 3.89 on 11/13/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 28,129 | 28,294 | 27,595 | ||
Shares Outstanding, K | 4,341 | 5,559 | 13,078 | ||
Annual Sales | 0 | 330,000 | 0 | ||
Annual Net Income | -88,970,000 | -20,890,000 | -29,220,000 | ||
Last Quarter Sales | 10,000 | 330,000 | 0 | ||
Last Quarter Net Income | -12,090,000 | -5,880,000 | -5,070,000 | ||
60-Month Beta | 0.66 | 1.64 | 1.05 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.18 on 12/01/23 | -1.08 on 11/12/24 | -0.65 on 11/12/24 | ||
Latest Earnings Date | 04/02/24 | 11/11/24 | 11/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |